ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JOYCE DOBBERTIN M.D.,D.C.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,274Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 224

$425K Total Retail Price of All Prescriptions

Rank: 23 out of 224

376 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 376 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

9% of this provider’s 376 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 5,164 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
OMEPRAZOLE 267 211 1 3
LEVOTHYROXINE SODIUM 211 185 2 4
FUROSEMIDE 184 166 3 5
LISINOPRIL 176 154 4 2
SIMVASTATIN 159 116 5 1
ATENOLOL 158 111 6 13
METOPROLOL SUCCINATE 150 139 7 11
HYDROCHLOROTHIAZIDE 134 105 8 6
FENTANYL 121 107 S2 9 49
TRAMADOL HCL 110 91 10 18
CITALOPRAM HBR 105 97 11 15
LOSARTAN POTASSIUM 100 86 12 19
PREDNISONE 92 74 13 28
POTASSIUM CHLORIDE 91 69 14 24
HYDROCODONE-ACETAMINOPHEN 80 67 S3 15 12
ADVAIR DISKUS 79 51 16 23
GABAPENTIN 77 66 17 14
JANTOVEN 77 77 17 115
METFORMIN HCL 74 63 19 9
WARFARIN SODIUM 69 54 20 10
TAMSULOSIN HCL 69 54 20 30
AMLODIPINE BESYLATE 66 51 22 8
OXYCODONE HCL 63 24 S2 23 25
SPIRIVA 62 41 24 32
POLYETHYLENE GLYCOL 3350 62 43 24 48
PRAVASTATIN SODIUM 61 49 26 21
TRIAMCINOLONE ACETONIDE 61 57 26 93
MIRTAZAPINE 60 58 28 54
SERTRALINE HCL 59 32 29 17
ALLOPURINOL 59 50 29 40
FLUTICASONE PROPIONATE 58 52 31 45
FLUOXETINE HCL 55 40 32 37
CYMBALTA 51 27 33 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.